| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,155 |
11,156 |
$583K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,215 |
4,977 |
$434K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,662 |
5,413 |
$173K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,623 |
4,322 |
$149K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,450 |
2,388 |
$148K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,374 |
2,627 |
$65K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,447 |
3,112 |
$39K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
439 |
427 |
$37K |
| 87634 |
|
536 |
530 |
$35K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,018 |
2,943 |
$26K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
96 |
95 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
199 |
194 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,956 |
1,805 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
234 |
210 |
$2K |
| 87807 |
|
103 |
101 |
$1K |
| 81003 |
|
719 |
684 |
$918.43 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
16 |
13 |
$455.94 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$453.46 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$453.46 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
13 |
13 |
$447.61 |
| 71046 |
Radiologic examination, chest; 2 views |
17 |
14 |
$212.52 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
189 |
170 |
$135.06 |
| 81025 |
|
14 |
12 |
$89.16 |
| 94760 |
|
214 |
197 |
$73.30 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
29 |
29 |
$72.30 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$61.17 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12 |
12 |
$53.17 |
| 36415 |
Collection of venous blood by venipuncture |
85 |
75 |
$1.08 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
46 |
25 |
$0.00 |
| 99000 |
|
1,213 |
1,127 |
$0.00 |